STEAP1 (Six-Transmembrane Epithelial Antigen of the Prostate 1) is a protein that is primarily expressed in prostate tissue and belongs to the STEAP family. It is a transmembrane protein with six transmembrane domains, involved in the transport and signaling across the cell membrane. STEAP1 is highly expressed in prostate cells, while its expression is relatively low in other tissues. This makes it a potential biomarker for prostate cancer, particularly in the development of immunotherapies and targeted drugs for prostate cancer.
Genomeditech provides resources related to the STEAP1 target, including overexpression cell lines and antibodies, which can support the in vitro activity validation of STEAP1-targeting antibodies. These tools will assist researchers in better evaluating and optimizing the development of STEAP1-related drugs, advancing their application in tumor immunotherapy.
